Literature DB >> 20840212

Increasing liver transplantation waiting list mortality: a report from the Australian National Liver Transplantation Unit, Sydney.

E Prakoso1, D Verran, P Dilworth, G Kyd, P Tang, C Tse, D J Koorey, S I Strasser, M Stormon, A Shun, G Thomas, D Joseph, H Pleass, J Gallagher, R Allen, M Crawford, G W McCaughan, N A Shackel.   

Abstract

BACKGROUND: We aimed to describe the demand for liver transplantation (LTx) and patient outcomes on the waiting list at the Australian National Liver Transplantation Unit, Sydney over the last 20 years.
METHODS: We performed a retrospective analysis with the data divided into three eras: 1985-1993, 1994-2000 and 2001-2008.
RESULTS: The number of patients accepted for LTx increased from 320 to 372 and 548 (P < 0.001) with the number of LTx being performed increasing from 262 to 312 and 452 respectively (P < 0.001). The median adult recipient age increased from 45 to 48 and 52 years (P < 0.001) while it decreased in children from 4 to 2 and 1 years respectively (P = 0.001). In parallel, the deceased donor offers decreased from 1003 to 720 and 717 (P < 0.001). Methods to improve access to donor livers have been used with the use of split livers, extended criteria and non-heart beating donors, resulting in increased acceptance of deceased donor offers by 65% and 115% in the second and third eras when compared with the first era (P < 0.001). However, the adult median waiting time has increased from 23 to 41 and 120 days respectively (P < 0.001). This was associated with increased adult mortality on the waiting list from 23 to 40 and 122 respectively (P < 0.001).
CONCLUSIONS: Despite the increasing proportion of donor offers being used, the waiting list mortality is increasing. A solution to this problem is an increase in organ donation to keep pace with the escalating demand for LTx.
© 2010 The Authors. Internal Medicine Journal © 2010 Royal Australasian College of Physicians.

Entities:  

Mesh:

Year:  2010        PMID: 20840212     DOI: 10.1111/j.1445-5994.2010.02277.x

Source DB:  PubMed          Journal:  Intern Med J        ISSN: 1444-0903            Impact factor:   2.048


  5 in total

1.  It's a man's world: does orthotopic liver transplantation in the elderly male confer an additional risk on survival?

Authors:  Eoin Slattery; John E Hegarty; P Aiden McCormick
Journal:  Can J Gastroenterol       Date:  2012-10       Impact factor: 3.522

2.  Outcomes of patients with benign liver diseases undergoing living donor versus deceased donor liver transplantation.

Authors:  Chuan Li; Kai Mi; Tian fu Wen; Lu nan Yan; Bo Li; Jia ying Yang; Ming qing Xu; Wen tao Wang; Yong gang Wei
Journal:  PLoS One       Date:  2011-11-07       Impact factor: 3.240

3.  A Pilot Study Evaluating the Safety of Intravenously Administered Human Amnion Epithelial Cells for the Treatment of Hepatic Fibrosis.

Authors:  Rebecca Lim; Alexander Hodge; Gregory Moore; Euan M Wallace; William Sievert
Journal:  Front Pharmacol       Date:  2017-08-23       Impact factor: 5.810

Review 4.  Human Amnion Epithelial Cell Therapy for Chronic Liver Disease.

Authors:  Neil Andrewartha; George Yeoh
Journal:  Stem Cells Int       Date:  2019-08-07       Impact factor: 5.443

Review 5.  Current status of multimodal & combination therapy for hepatocellular carcinoma.

Authors:  Jian Yang; Lunan Yan; Wentao Wang
Journal:  Indian J Med Res       Date:  2012-09       Impact factor: 2.375

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.